Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

類似資料

• MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
  著者:: Løkkegaard, Sanne, 等
  出版事項: (2021)
• Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
  著者:: Larsen, Sarah L, 等
  出版事項: (2015)
• Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer
  著者:: Göthlin Eremo, Anna, 等
  出版事項: (2020)
• Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
  著者:: Løkkegaard, S, 等
  出版事項: (2011)
• Endocrine treatment of physiological gynaecomastia: Tamoxifen seems to be effective
  著者:: Khan, Hamed N, 等
  出版事項: (2003)